Form 8-K - Current report:
SEC Accession No. 0001193125-25-039211
Filing Date
2025-02-27
Accepted
2025-02-27 16:05:20
Documents
16
Period of Report
2025-02-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d859484d8k.htm   iXBRL 8-K 35635
2 EX-10.1 d859484dex101.htm EX-10.1 247480
3 EX-10.2 d859484dex102.htm EX-10.2 22118
  Complete submission text file 0001193125-25-039211.txt   533846

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20250222.xsd EX-101.SCH 4471
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20250222_def.xml EX-101.DEF 13889
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20250222_lab.xml EX-101.LAB 23245
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20250222_pre.xml EX-101.PRE 14858
19 EXTRACTED XBRL INSTANCE DOCUMENT d859484d8k_htm.xml XML 6193
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 25678658
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)